Health and Fitness Health and Fitness
Thu, March 29, 2012
[ Thu, Mar 29th 2012 ] - Market Wire
VentriPoint 3D Heart Analysis System First to Be Approved for Pulmonary Hypertension in Europe
[ Thu, Mar 29th 2012 ] - Market Wire
Cempra, Inc. to Present at the Needham 11th Annual Health Care Conference
[ Thu, Mar 29th 2012 ] - Market Wire
Omeros Reports Allowance of Additional Patent for Ophthalmology Product OMS302
[ Thu, Mar 29th 2012 ] - Market Wire
Sinovac Announces Director Appointment
[ Thu, Mar 29th 2012 ] - Market Wire
Sinovac's EV71 Vaccine Phase I Clinical Data for .. ic Hand, Foot, Mouth Disease Published in Vaccine
[ Thu, Mar 29th 2012 ] - Market Wire
Five Oral Presentations on Clinical Experience Wi .. at Society of Interventional Radiology Conference
[ Thu, Mar 29th 2012 ] - Market Wire
Astex Pharmaceuticals to Present at AACR Annual Meeting
[ Thu, Mar 29th 2012 ] - Market Wire
AirWare Labs Announces the Release of "BREATHE," First of the New Product Line, "AIR"
Wed, March 28, 2012
[ Wed, Mar 28th 2012 ] - Market Wire
Forest Laboratories and Almirall Announce FDA has .. Extended the Review Period for Aclidinium Bromide
[ Wed, Mar 28th 2012 ] - Market Wire
Illumina Advises Stockholders to Defer Taking Any Action in Response to Rocheas Increased Offer
[ Wed, Mar 28th 2012 ] - Market Wire
Syneron to Highlight New Opportunities &;&# .. dy Shaping Market at the 2012 Anti-Aging Medicine
[ Wed, Mar 28th 2012 ] - Market Wire
Roche increases offer price for Illumina shares to US$ 51.00 per share
[ Wed, Mar 28th 2012 ] - Market Wire
The Law Firm of Levi amp;; Korsinsky, LLP .. Possible Breaches of Fiduciary Duty by the Board
[ Wed, Mar 28th 2012 ] - Market Wire
Unilife Analyst and Investor Day Presentation Available on Company's Website
[ Wed, Mar 28th 2012 ] - Market Wire
Lilly's Anti-IL-17 Monoclonal Antibody, Ixekizuma .. ase II Study in Patients With Chronic Plaque Psor
[ Wed, Mar 28th 2012 ] - Market Wire
Amgen Announces Phase 2 Study Results for Brodalu .. que Psoriasis Published in the New England Journa
[ Wed, Mar 28th 2012 ] - Market Wire
Hanger Orthopedic Group, Inc. Announces First Quarter 2012 Earnings Release Conference Call
[ Wed, Mar 28th 2012 ] - Market Wire
Horizon Pharma Files Patent Infringement Lawsuit .. utical, Inc. for Filing an ANDA Against DUEXIS(R)
[ Wed, Mar 28th 2012 ] - Market Wire
MethylGene to Present at the American Association for Cancer Research (AACR) Annual Meeting
[ Wed, Mar 28th 2012 ] - Market Wire
Hubei Minkang Pharmaceutical Ltd. Signs a MOU With Hubei Merryclin Pharmaceuticals
[ Wed, Mar 28th 2012 ] - Market Wire
Threshold Pharmaceuticals Announces Multiple Data .. tations on TH-302 at the 2012 AACR Annual Meeting
[ Wed, Mar 28th 2012 ] - Market Wire
Amerigroup Preventing Preterm Births with Affordable Drug Therapy
[ Wed, Mar 28th 2012 ] - Market Wire
Omeros to Present at Two Upcoming Conferences
[ Wed, Mar 28th 2012 ] - Market Wire
WellPoint to Hold Conference Call and Webcast to Discuss First Quarter Results on April 25, 2012
[ Wed, Mar 28th 2012 ] - Market Wire
Sangamo BioSciences Announces Presentation at Needham Healthcare Conference
[ Wed, Mar 28th 2012 ] - Market Wire
Oncothyreon Announces Proposed Public Offering of Common Stock
[ Wed, Mar 28th 2012 ] - Market Wire
Digirad Announces Departure of CFO Richard B. Slansky;; Initiates Search for Replacement
[ Wed, Mar 28th 2012 ] - Market Wire
Peregrine Pharmaceuticals Announces Receipt of Notice From NASDAQ
[ Wed, Mar 28th 2012 ] - Market Wire
Warnex Debentures in Default
[ Wed, Mar 28th 2012 ] - Market Wire
Theratechnologies to Present at Needham Annual Healthcare Conference

Theratechnologies to Present at Needham Annual Healthcare Conference


Published on 2012-03-28 11:50:56 - Market Wire
  Print publication without navigation


March 28, 2012 14:47 ET

Media Advisory: Theratechnologies to Present at Needham Annual Healthcare Conference

MONTREAL, CANADA--(Marketwire - March 28, 2012) - Theratechnologies Inc. (Theratechnologies) (TSX:TH)(NASDAQ:THER) today announced that John-Michel T. Huss, President and Chief Executive Officer of Theratechnologies, is scheduled to present at the 11th Annual Needham Healthcare Conference in New York City, on April 3, 2012 at 8:00a.m. ET. Financial analysts, media and other interested individuals are invited to listen to the live webcast on Theratechnologies' corporate website at [ www.theratech.com ].

About Theratechnologies

Theratechnologies (TSX:TH)(NASDAQ:THER) is a specialty pharmaceutical company that discovers and develops innovative therapeutic peptide products, with an emphasis on growth-hormone releasing factor (GRF) peptides. Further information about Theratechnologies is available on the Company's website at [ www.theratech.com ], on SEDAR at [ www.sedar.com ] and on the Securities and Exchange Commission's website at [ www.sec.gov ].



Contributing Sources